Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now later-stage tilt small index

Adult Acute Myeloid Leukemia: later-stage trial registry

1 of 2 indexed Adult Acute Myeloid Leukemia trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Adult Acute Myeloid Leukemia: 2 US clinical trials tracked, 1 recruiting.

Adult Acute Myeloid Leukemia is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Neovii Biotech, running 1 of these trials.

Enrollment posture brief

Registry condition adult-acute-myeloid-leukemia

OPEN 1 | RECR 50% | LATE 2 | EARLY 0 | RANK #7188 | SPON 1

Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Adult Acute Myeloid Leuk (th…50%
Open-enrollment share among volume-matched conditions near Adult Acute Myeloid Leukemia

Adult Acute Myeloid Leukemia lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Adult Acute Myeloid Leukemia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Adult Acute Myeloid Leukemia is recruiting above its size-band peers.

    1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 32

Phase Distribution

PhaseTrial count
Phase 3 2

Top Sponsors

Neovii Biotech 1 trials
Priothera SAS 1 trials

Named interventions

Most-linked intervention names on Adult Acute Myeloid Leukemia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

US-ATG-F Biological
1 trials
mocravimod Drug
1 trials
Placebo Biological
1 trials

US sites by state

Facility locations filed on Adult Acute Myeloid Leukemia trials. A trial with sites in several states counts in each.

Pennsylvania 2 trials
Oregon 2 trials
New York 2 trials
Massachusetts 2 trials
Louisiana 2 trials
Kansas 2 trials
Florida 2 trials
California 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Adult Acute Myeloid Leukemia page

2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Adult Acute Myeloid Leukemia trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Neovii Biotech sponsors the most Adult Acute Myeloid Leukemia trials on record, review their full trial history before evaluating a specific study. See Neovii Biotech's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Adult Acute Myeloid Leukemia condition card totals 2 registered trials; most-linked intervention US-ATG-F; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.